Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
6 hedge funds and large institutions have $189K invested in Genetic Technologies Ltd. in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
88% more capital invested
Capital invested by funds: $100K → $189K (+$88.9K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$79.5K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$20.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$39.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.38K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$312 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $100K | +$79.5K | +34,596 | New |
|
|
2
Morgan Stanley
New York
| $50.5K | -$39.3K | -17,089 | -49% |
|
|
3
BNP Paribas Financial Markets
Paris,
France
| $26.3K | +$20.9K | +9,100 | New |
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $10.8K | – | – | – |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.16K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $633 | -$6.38K | -2,775 | -93% |
|
|
7
Wells Fargo
San Francisco,
California
| – | -$312 | -130 | Closed |
|
GENE Hedge Fund Activity: Q1 2024 in Review
6 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2024, worth a combined $189K — up 88% from $100K a quarter earlier.
Fund positioning in GENE was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $79.5K. The largest seller was Morgan Stanley, cutting an estimated $39.3K.
- 6 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $189K of Genetic Technologies Ltd. stock for Q1 2024, up 88% quarter-over-quarter.
- 2 funds opened new Genetic Technologies Ltd. positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest Genetic Technologies Ltd. buyer in Q1 2024 was Susquehanna International Group, an estimated $79.5K added.
- The largest Genetic Technologies Ltd. seller in Q1 2024 was Morgan Stanley, an estimated $39.3K sold.
Based on aggregated 13F filings for Q1 2024.